Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the Treatment of Seasonal Allergic Rhinitis
Clinical trial NCT00790023 · COMPLETED
Trial details
- NCT number
- NCT00790023
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-01
- Primary completion
- 2009-02-01
- Enrollment
- 707
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.